Search Within

Heiko Schoder

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (89)
  2. Meeting Abstract (53)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (144)
  2. Molecular Imaging and Therapy Service (144)
  3. Radiology, Department of (144)
  4. Biostatistics Service (136)
  5. Department of Medicine (108)
  6. Center for Pancreatic Cancer Research (75)

More Groups

People
  1. Mithat Gonen (47)
  2. Steven Larson (36)
  3. Maria Palomba (29)
  4. Audrey Mauguen (28)
  5. John Humm (28)
  6. Andrew Zelenetz (27)

More People

Years
  1. 2025 (7)
  2. 2024 (13)
  3. 2023 (16)
  4. 2022 (8)
  5. 2021 (13)
  6. 2020 (8)

More Years

Publications
  1. Journal of Nuclear Medicine (27)
  2. Journal of Clinical Oncology (20)
  3. Blood (18)
  4. International Journal of Radiation Oncology, Biology, Physics (13)
  5. European Journal of Nuclear Medicine and Molecular Imaging (12)
  6. Clinical Cancer Research (5)

More Publications

Publishers
  1. Society of Nuclear Medicine (27)
  2. American Society of Hematology (21)
  3. American Society of Clinical Oncology (20)
  4. Springer (20)
  5. Elsevier Inc. (16)
  6. American Association for Cancer Research (6)

More Publishers

Results (144)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The quest for an accurate functional tumor volume with (68)Ga-DOTATATE PET/CT
    Journal Article

    Reddy, R. P.; Schmidtlein, C. R.; Giancipoli, R. G.; Mauguen, A.; LaFontaine, D.; Schoder, H.; Bodei, L.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
    Journal Article

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schöder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prognostic value of [(18)F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
    Journal Article

    Krebs, S.; Mauguen, A.; Yildirim, O.; Hatzoglou, V.; Francis, J. H.; Schaff, L. R.; Mellinghoff, I. K.; Schöder, H.; Grommes, C.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer
    Journal Article

    de Souza França, P. D.; Kossatz, S.; Brand, C.; Karassawa Zanoni, D.; Roberts, S.; Guru, N.; Adilbay, D.; Mauguen, A.; Valero Mayor, C.; Weber, W. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save